BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 33098813)

  • 1. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
    DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
    Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of COVID-19 Respiratory Complications during Pregnancy are Associated with Degree of Lymphopenia and Neutrophil to Lymphocyte Ratio on Presentation: A Multicenter Cohort Study.
    Lasser DM; Chervenak J; Moore RM; Li T; Knight C; Teo HO; Malhotra Y;
    Am J Perinatol; 2021 Oct; 38(12):1236-1243. PubMed ID: 34396499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
    Wang Z; Wang Z; Xiong G
    Int J Gynaecol Obstet; 2020 Sep; 150(3):312-317. PubMed ID: 32510581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
    Kalafat E; Prasad S; Birol P; Tekin AB; Kunt A; Di Fabrizio C; Alatas C; Celik E; Bagci H; Binder J; Le Doare K; Magee LA; Mutlu MA; Yassa M; Tug N; Sahin O; Krokos P; O'brien P; von Dadelszen P; Palmrich P; Papaioannou G; Ayaz R; Ladhani SN; Kalantaridou S; Mihmanli V; Khalil A
    Am J Obstet Gynecol; 2022 Mar; 226(3):403.e1-403.e13. PubMed ID: 34582796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysfunction following COVID-19, especially in severe patients.
    Song CY; Xu J; He JQ; Lu YQ
    Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
    Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
    Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
    Liu Y; Liao W; Wan L; Xiang T; Zhang W
    Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
    Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
    Front Immunol; 2021; 12():626235. PubMed ID: 33584733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining laboratory parameters in pregnant women with severe COVID-19.
    Djusad S; Irwinda R; Harzif AK; Surya R; Wibowo N; Saroyo YB; Adjie JS
    SAGE Open Med; 2022; 10():20503121221132168. PubMed ID: 36277440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020-5 March 2021.
    Galang RR; Newton SM; Woodworth KR; Griffin I; Oduyebo T; Sancken CL; Olsen EO; Aveni K; Wingate H; Shephard H; Fussman C; Alaali ZS; Silcox K; Siebman S; Halai UA; Lopez CD; Lush M; Sokale A; Barton J; Chaudhary I; Patrick PH; Schlosser L; Reynolds B; Gaarenstroom N; Chicchelly S; Read JS; de Wilde L; Mbotha D; Azziz-Baumgartner E; Hall AJ; Tong VT; Ellington S; Gilboa SM;
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S17-S23. PubMed ID: 34021332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.
    Shi S; Nie B; Chen X; Cai Q; Lin C; Zhao G; Zhang X
    J Clin Lab Anal; 2021 Jan; 35(1):e23692. PubMed ID: 33389777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection.
    Sherer ML; Lei J; Creisher PS; Jang M; Reddy R; Voegtline K; Olson S; Littlefield K; Park HS; Ursin RL; Ganesan A; Boyer T; Elsayed N; Brown DM; Walch SN; Antar AAR; Manabe YC; Jones-Beatty K; Golden WC; Satin AJ; Sheffield JS; Pekosz A; Klein SL; Burd I
    Am J Obstet Gynecol; 2021 Sep; 225(3):301.e1-301.e14. PubMed ID: 33798476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study.
    Wei L; Gao X; Chen S; Zeng W; Wu J; Lin X; Zhang H; Mwamaka Sharifu L; Chen L; Feng L; Wang S
    J Med Internet Res; 2020 Aug; 22(8):e19642. PubMed ID: 32750000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection.
    Bruno AM; Allshouse AA; Benson AE; Yost CC; Metz TD; Varner MW; Silver RM; Branch DW
    Am J Perinatol; 2024 May; 41(S 01):e3202-e3209. PubMed ID: 37967868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematological characteristics of 88 patients with COVID-19.
    Zhang H; Cao X; Kong M; Mao X; Huang L; He P; Pan S; Li J; Lu Z
    Int J Lab Hematol; 2020 Dec; 42(6):780-787. PubMed ID: 32779860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.